Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Materials (Basel) ; 14(12)2021 Jun 09.
Artículo en Inglés | MEDLINE | ID: mdl-34207489

RESUMEN

Multilayer reduced graphene oxide (mrGO) was chemically modified by electroless plating of copper on surface to form mrGO-Cu. The scanning electron microscope (SEM) and transmission electron microscope (TEM) analysis revealed that nano-Cu particles were uniformly dispersed on the surface of mrGO. The mrGO-Cu powders were further utilized as reinforcements for aluminum (Al) matrix and the mrGO-Cu/Al composite was successfully fabricated through clad rolling of milled powder. The tribological properties of the mrGO-Cu/Al composites were explored. The tribological results show that the mrGO-Cu could reduce the friction coefficient and wear loss of mrGO-Cu/Al composites, since the mrGO-Cu participated in lubricating processes due to the formation of a transfer layer on the contact surface. Furthermore, it is found that the composition of mrGO-Cu could significantly influence the tribological properties of the mrGO-Cu/Al composites. The composites with 4% of mrGO-Cu for composites exhibited the best tribological behavior, which transformed from adhesive wear to abrasive wear, due to the formation of a graphite lubricating film.

2.
J Recept Signal Transduct Res ; 40(5): 479-485, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-32429710

RESUMEN

Parkinson's disease is a common progressive neurodegenerative disorder associated with inflammation. Platycodin D (PLD) is a triterpenesaponin that has anti-inflammatory and neuro-protective effects. However, the role of PLD in Parkinson's disease has not been fully investigated. In the current study, we investigated the effect of PLD on 1-methyl-4-phenylpyridinium (MPP+)-induced inflammatory response in BV-2 cells. Our results showed that PLD treatment improved the cell viability of MPP+-induced BV-2 cells. PLD significantly inhibited the levels of inflammatory mediators including nitric oxide (NO), prostaglandin E2 (PGE2), inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) in MPP+-treated BV-2 cells. The increased productions of inflammatory cytokines tumor necrosis factor-α (TNF-α), interleukin 1ß (IL-1ß), and IL-6 in MPP+-treated BV-2 cells were also suppressed by PLD. Furthermore, PLD inhibited the activation of TLR4/MyD88/NF-κB pathway in MPP+-treated BV-2 cells. Overexpression of TLR4 reversed the protective effects of PLD on MPP+-treated BV-2 cells. Collectively, PLD protected BV-2 cells from MPP+-induced inflammatory response via regulating the TLR4-MyD88-NF-κB signaling pathway.


Asunto(s)
Inflamación/tratamiento farmacológico , Factor 88 de Diferenciación Mieloide/genética , Enfermedad de Parkinson/genética , Saponinas/farmacología , Receptor Toll-Like 4/genética , Triterpenos/farmacología , 1-Metil-4-fenilpiridinio/toxicidad , Animales , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Inflamación/inducido químicamente , Inflamación/genética , Inflamación/patología , Interleucina-1beta/genética , Interleucina-6/genética , Ratones , FN-kappa B/genética , Fármacos Neuroprotectores/farmacología , Enfermedad de Parkinson/tratamiento farmacológico , Enfermedad de Parkinson/patología
3.
Neuropharmacology ; 170: 108054, 2020 06 15.
Artículo en Inglés | MEDLINE | ID: mdl-32217088

RESUMEN

Depression-alcohol addiction comorbidity is a common clinical phenomenon. Alcohol exposure in adolescence has been shown to induce depression-like behaviors in rodents. However, the mechanism of action for this type of depression remains unclear. Previous studies have reported that several different types of stress, such as chronic unpredictable stress and early social isolation, trigger depression-like symptoms in mice by inducing hippocampal microglial decline, which is mediated by the initial activation of the microglial cells. Since alcohol also activates microglia, we evaluated the dynamic changes in hippocampal microglia in mice receiving adolescent intermittent alcohol exposure (AIE). Our results showed that 14 days of AIE, followed by 21 days period of no treatment, induced behavioral abnormalities as well as a significant loss and dystrophy of hippocampal microglia in mice. We found that this AIE-induced decline in hippocampal microglia was mediated by both microglial activation and apoptosis, as (i) 1 day of alcohol exposure induced a distinct activation of hippocampal microglia followed by their apoptosis, and (ii) blocking the initial activation of hippocampal microglia by pretreatment with minocycline suppressed the AIE-induced apoptosis and loss of hippocampal microglia as well as the AIE-induced depression-like symptoms. Lipopolysaccharide (LPS), a classical activator of microglia, ameliorated the AIE-induced depression-like symptoms by reversing the decline in the hippocampal microglia. These results reveal a possible mechanism for AIE-induced depression and demonstrate that the restoration of hippocampal microglial homeostasis may be a therapeutic strategy for depression induced by alcohol intake and withdrawal.


Asunto(s)
Consumo de Bebidas Alcohólicas/efectos adversos , Apoptosis/efectos de los fármacos , Depresión/inducido químicamente , Etanol/toxicidad , Hipocampo/efectos de los fármacos , Microglía/efectos de los fármacos , Factores de Edad , Consumo de Bebidas Alcohólicas/patología , Consumo de Bebidas Alcohólicas/psicología , Animales , Apoptosis/fisiología , Proliferación Celular/efectos de los fármacos , Proliferación Celular/fisiología , Depresión/patología , Depresión/psicología , Etanol/administración & dosificación , Hipocampo/patología , Masculino , Ratones , Microglía/patología , Minociclina/farmacología
4.
Eur J Pharmacol ; 858: 172500, 2019 Sep 05.
Artículo en Inglés | MEDLINE | ID: mdl-31238064

RESUMEN

Anthocyanins, a class of water soluble flavonoids extracted from plants like berries and soybean seed, have been shown to display obvious anti-oxidative, anti-inflammatory, and anti-apoptotic activities. They are recommended as a supplementation for prevention and/or treatment of disorders ranging from cardiovascular disease, metabolic syndrome, and cancer. In the central nervous system (CNS), anthocyanins and its major component cyanidin-3-O-glucoside (C3G) have been reported to produce preventive and/or therapeutic activities in a wide range of disorders, such as cerebral ischemia, Alzheimer's disease, Parkinson's disease, multiple sclerosis, and glioblastoma. Both anthocyanins and C3G can also affect some important processes in aging, including neuronal apoptosis and death as well as learning and memory impairment. Further, the anthocyanins and C3G have been shown to prevent neuro-toxicities induced by different toxic factors, such as lipopolysaccharide, hydrogen peroxide, ethanol, kainic acid, acrolein, glutamate, and scopolamine. Mechanistic studies have shown that inhibition of oxidative stress and neuroinflammation are two critical mechanisms by which anthocyanins and C3G produce protective effects in CNS disorder prevention and/or treatment. Other mechanisms, including suppression of c-Jun N-terminal kinase (JNK) activation, amelioration of cellular degeneration, activation of the brain-derived neurotrophic factor (BDNF) signaling, and restoration of Ca2+ and Zn2+ homeostasis, may also mediate the neuroprotective effects of anthocyanins and C3G. In this review, we summarize the pharmacological effects of anthocyanins and C3G in CNS disorders as well as their possible mechanisms, aiming to get a clear insight into the role of anthocyanins in the CNS.


Asunto(s)
Antocianinas/farmacología , Sistema Nervioso Central/efectos de los fármacos , Glucósidos/farmacología , Fármacos Neuroprotectores/farmacología , Animales , Antocianinas/uso terapéutico , Sistema Nervioso Central/metabolismo , Sistema Nervioso Central/patología , Enfermedades del Sistema Nervioso Central/tratamiento farmacológico , Enfermedades del Sistema Nervioso Central/metabolismo , Enfermedades del Sistema Nervioso Central/patología , Enfermedades del Sistema Nervioso Central/prevención & control , Glucósidos/uso terapéutico , Humanos , Fármacos Neuroprotectores/uso terapéutico
5.
Toxicol Appl Pharmacol ; 337: 104-110, 2017 12 15.
Artículo en Inglés | MEDLINE | ID: mdl-29104011

RESUMEN

The attachment of monocytes to human brain microvascular endothelial cells (HBMVEs) caused by oxidized low-density lipoprotein (ox-LDL) is associated with an early event and the pathological progression of cerebrovascular diseases. Oxytocin (OT) is a human peptide hormone that is traditionally used as a medication to facilitate childbirth. However, little information is available regarding the physiological function of OT in brain endothelial dysfunction. In the present study, our results indicate that the oxytocin receptor (OTR) was expressed in human brain microvascular endothelial cells (HBMVEs) and was upregulated in response to ox-LDL in a concentration-dependent manner. Notably, OT significantly suppressed ox-LDL-induced attachment of THP-1 monocytes to HBMVEs. Furthermore, we found that OT reduced the expression of adhesion molecules, such as VCAM-1 and E-selectin. Interestingly, it was shown that OT could restore ox-LDL-induced reduction of KLF4 in HBMVEs. Importantly, knockdown of KLF4 abolished the inhibitory effects of OT on ox-LDL-induced expressions of VCAM-1 and E-selectin as well as the adhesion of human monocytic THP-1 cells to endothelial HBMVEs. Mechanistically, we found that the stimulatory effects of OT on KLF4 expression are mediated by the MEK5/MEF2A pathway.


Asunto(s)
Encéfalo/irrigación sanguínea , Adhesión Celular/efectos de los fármacos , Células Endoteliales/efectos de los fármacos , Lipoproteínas LDL/farmacología , Microvasos/efectos de los fármacos , Monocitos/efectos de los fármacos , Oxitocina/farmacología , Línea Celular Tumoral , Técnicas de Cocultivo , Relación Dosis-Respuesta a Droga , Selectina E/genética , Selectina E/metabolismo , Células Endoteliales/metabolismo , Humanos , Factor 4 Similar a Kruppel , Factores de Transcripción de Tipo Kruppel/genética , Factores de Transcripción de Tipo Kruppel/metabolismo , MAP Quinasa Quinasa 5/genética , MAP Quinasa Quinasa 5/metabolismo , Factores de Transcripción MEF2/genética , Factores de Transcripción MEF2/metabolismo , Microvasos/metabolismo , Monocitos/metabolismo , Interferencia de ARN , Receptores de Oxitocina/agonistas , Receptores de Oxitocina/genética , Receptores de Oxitocina/metabolismo , Transducción de Señal/efectos de los fármacos , Transfección , Molécula 1 de Adhesión Celular Vascular/genética , Molécula 1 de Adhesión Celular Vascular/metabolismo
6.
Prog Neuropsychopharmacol Biol Psychiatry ; 79(Pt B): 258-267, 2017 10 03.
Artículo en Inglés | MEDLINE | ID: mdl-28625859

RESUMEN

Depression is a world-wide disease with no effective therapeutic methods. Increasing evidence indicates that astrocytic pathology contributes to the formation of depression. In this study, we investigated the effects of harmine, a natural ß-carboline alkaloid and potent hallucinogen, known to modulate astrocytic glutamate transporters, on chronic unpredictable stress (CUS)-induced depressive-like behaviors and astrocytic dysfunctions. Results showed that harmine treatment (10, 20mg/kg) protected the mice against the CUS-induced increases in the immobile time in the tail suspension test (TST) and forced swimming test (FST), and also reversed the reduction in sucrose intake in the sucrose preference experiment. Harmine treatment (20mg/kg) prevented the reductions in brain-derived neurotrophic factor (BDNF) protein levels and hippocampal neurogenesis induced by CUS. In addition, harmine treatment (20mg/kg) increased the protein expression levels of glutamate transporter 1 (GLT-1) and prevented the CUS-induced decreases in glial fibrillary acidic protein (GFAP) protein expressions in the prefrontal cortex and hippocampus, suggesting that restoration of astrocytic functions may be a potential mechanism underlying the antidepressant-like effects of harmine. This opinion was proved by the results that administration of mice with l-Alpha-Aminoadipic Acid (L-AAA), a gliotoxin specific for astrocytes, attenuated the antidepressant-like effects of harmine, and prevented the improvement effects of harmine on BDNF protein levels and hippocampal neurogenesis. These results provide further evidence to confirm that astrocytic dysfunction contributes critically to the development of depression and that harmine exerts antidepressant-like effects likely through restoration of astrocytic functions.


Asunto(s)
Antidepresivos/farmacología , Astrocitos/efectos de los fármacos , Trastorno Depresivo/tratamiento farmacológico , Harmina/farmacología , Anhedonia/efectos de los fármacos , Anhedonia/fisiología , Animales , Astrocitos/metabolismo , Astrocitos/patología , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Enfermedad Crónica , Trastorno Depresivo/metabolismo , Trastorno Depresivo/patología , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Transportador 2 de Aminoácidos Excitadores/metabolismo , Fluoxetina/farmacología , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Hipocampo/patología , Masculino , Ratones Endogámicos C57BL , Neurogénesis/efectos de los fármacos , Neurogénesis/fisiología , Corteza Prefrontal/efectos de los fármacos , Corteza Prefrontal/metabolismo , Corteza Prefrontal/patología , Estrés Psicológico/tratamiento farmacológico , Estrés Psicológico/metabolismo , Estrés Psicológico/patología , Incertidumbre
7.
Int J Neuropsychopharmacol ; 20(6): 485-497, 2017 06 01.
Artículo en Inglés | MEDLINE | ID: mdl-28339691

RESUMEN

Background: Z-guggulsterone, an active compound extracted from the gum resin of the tree Commiphora mukul, has been shown to improve animal memory deficits via activating the brain-derived neurotrophic factor signaling pathway. Here, we investigated the antidepressant-like effect of Z-guggulsterone in a chronic unpredictable stress mouse model of depression. Methods: The effects of Z-guggulsterone were assessed in mice with the tail suspension test and forced swimming test. Z-guggulsterone was also investigated in the chronic unpredictable stress model of depression with fluoxetine as the positive control. Changes in hippocampal neurogenesis as well as the brain-derived neurotrophic factor signaling pathway after chronic unpredictable stress/Z-guggulsterone treatment were investigated. The tryptophan hydroxylase inhibitor and the tyrosine kinase B inhibitor were also used to explore the antidepressant-like mechanisms of Z-guggulsterone. Results: Z-guggulsterone (10, 30 mg/kg) administration protected the mice against the chronic unpredictable stress-induced increases in the immobile time in the tail suspension test and forced swimming test and also reversed the reduction in sucrose intake in sucrose preference experiment. Z-guggulsterone (10, 30 mg/kg) administration prevented the reductions in brain-derived neurotrophic factor protein expression levels as well as the phosphorylation levels of cAMP response element binding protein, extracellular signal-regulated kinase 1/2, and protein kinase B in the hippocampus and cortex induced by chronic unpredictable stress. Z-guggulsterone (10, 30 mg/kg) treatment also improved hippocampal neurogenesis in chronic unpredictable stress-treated mice. Blockade of the brain-derived neurotrophic factor signal, but not the monoaminergic system, attenuated the antidepressant-like effects of Z-guggulsterone. Conclusions: Z-guggulsterone exhibits antidepressant activity via activation of the brain-derived neurotrophic factor signaling pathway and upregulation of hippocampal neurogenesis.


Asunto(s)
Antidepresivos/farmacología , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Trastorno Depresivo/tratamiento farmacológico , Trastorno Depresivo/metabolismo , Pregnenodionas/farmacología , Animales , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/metabolismo , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Fluoxetina/farmacología , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Masculino , Ratones Endogámicos C57BL , Neurogénesis/efectos de los fármacos , Neurogénesis/fisiología , Proteínas Proto-Oncogénicas c-akt/metabolismo , Transducción de Señal/efectos de los fármacos
8.
Langmuir ; 28(24): 9103-12, 2012 Jun 19.
Artículo en Inglés | MEDLINE | ID: mdl-22449096

RESUMEN

A rich variety of dipolar and higher order plasmon resonances have been predicted for nanoscale cubes and parallopipeds of silver, in contrast to the simple dipolar modes found on silver nanospheres or nanorods. However, in general, these multimode resonances are not readily detected in experimental colloidal ensembles, due primarily to the usual variation of size and shape of the particles obscuring or blending the individual extinction peaks. Recently, methods have been found to prepare silver parallopipeds with unprecedented shape control by nucleating the silver onto a tightly controlled suspension of gold nanorods (Okuno, Y.; Nishioka, K.; Kiya, A.; Nakashima, N.; Ishibashi, A.; Niidome, Y. Uniform and Controllable Preparation of Au-Ag Core-Shell Nanorods Using Anisotropic Silver Shell Formation on Gold Nanorods. Nanoscale 2010, 2, 1489-1493). The optical extinction spectra of suspensions of such monodisperse particles are found to contain multiple extinction peaks, which we show here to be due to the multimode resonances predicted by theoretical studies. Control of the radius of the nanoparticle edges is found to be an effective way to turn some of these modes on or off. These nanoparticles provide a flexible platform for the excitation, manipulation, and exploration of higher order plasmon resonances.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA